Chandra Bhagat Pharma Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Chandra Bhagat Pharma has a total shareholder equity of ₹290.1M and total debt of ₹164.3M, which brings its debt-to-equity ratio to 56.6%. Its total assets and total liabilities are ₹1.0B and ₹728.0M respectively. Chandra Bhagat Pharma's EBIT is ₹31.7M making its interest coverage ratio 2.5. It has cash and short-term investments of ₹51.0M.
Anahtar bilgiler
56.6%
Borç/özkaynak oranı
₹164.27m
Borç
| Faiz karşılama oranı | 2.5x |
| Nakit | ₹50.97m |
| Eşitlik | ₹290.09m |
| Toplam yükümlülükler | ₹727.96m |
| Toplam varlıklar | ₹1.02b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 542934's short term assets (₹979.2M) exceed its short term liabilities (₹710.6M).
Uzun Vadeli Yükümlülükler: 542934's short term assets (₹979.2M) exceed its long term liabilities (₹17.4M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 542934's net debt to equity ratio (39.1%) is considered satisfactory.
Borcun Azaltılması: 542934's debt to equity ratio has reduced from 216.3% to 56.6% over the past 5 years.
Borç Kapsamı: 542934's debt is well covered by operating cash flow (37.6%).
Faiz Kapsamı: 542934's interest payments on its debt are not well covered by EBIT (2.5x coverage).